Related Experiment Videos

Chemotherapy for neuroblastoma: is it all or none?

John M Maris¹, Robert P Castleberry

¹Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. maris@email.chop.edu

Journal of Pediatric Hematology/Oncology

|July 9, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity.

Nature communications·2026

A generalizable system for antigenic peptide targeting across HLA-I allotypes.

bioRxiv : the preprint server for biology·2026

IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancers.

Cancer discovery·2026

Preclinical Activity of the B7-H3-Targeting Antibody-Drug Conjugate Vobramitamab Duocarmazine in Pediatric Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumors.

Science advances·2026

Defining the Functional Role and Potential as an Immunotherapeutic Target of ALCAM in Neuroblastoma.

Molecular cancer therapeutics·2025

See all related articles